Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 24% ± 6% | |
B cell | 4 studies | 19% ± 2% | |
naive B cell | 3 studies | 17% ± 2% | |
precursor B cell | 3 studies | 22% ± 4% | |
epithelial cell | 3 studies | 34% ± 13% | |
glutamatergic neuron | 3 studies | 23% ± 6% | |
neuron | 3 studies | 22% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 20% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3455.65 | 1445 / 1445 | 100% | 59.82 | 183 / 183 |
intestine | 100% | 3628.40 | 966 / 966 | 100% | 49.47 | 527 / 527 |
ovary | 100% | 3948.97 | 180 / 180 | 100% | 61.99 | 430 / 430 |
prostate | 100% | 4023.60 | 245 / 245 | 100% | 37.66 | 502 / 502 |
stomach | 100% | 2687.94 | 359 / 359 | 100% | 49.13 | 286 / 286 |
uterus | 100% | 4338.36 | 170 / 170 | 100% | 52.69 | 459 / 459 |
brain | 100% | 2900.83 | 2638 / 2642 | 100% | 67.81 | 705 / 705 |
thymus | 100% | 4807.70 | 653 / 653 | 100% | 49.89 | 604 / 605 |
breast | 100% | 4173.69 | 459 / 459 | 100% | 50.23 | 1116 / 1118 |
skin | 100% | 3572.67 | 1809 / 1809 | 100% | 79.33 | 471 / 472 |
lung | 100% | 3351.56 | 578 / 578 | 100% | 50.97 | 1152 / 1155 |
kidney | 100% | 3730.38 | 89 / 89 | 100% | 44.50 | 898 / 901 |
bladder | 100% | 3639.38 | 21 / 21 | 100% | 49.62 | 502 / 504 |
adrenal gland | 100% | 4280.08 | 258 / 258 | 99% | 35.32 | 228 / 230 |
pancreas | 100% | 2083.10 | 327 / 328 | 99% | 37.48 | 176 / 178 |
liver | 100% | 1712.64 | 226 / 226 | 94% | 24.27 | 382 / 406 |
adipose | 100% | 3957.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 56.89 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 61.44 | 29 / 29 |
spleen | 100% | 4901.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 54.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.27 | 1 / 1 |
blood vessel | 100% | 3268.47 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 1707.74 | 859 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1499.08 | 797 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2830.31 | 903 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030071 | Biological process | regulation of mitotic metaphase/anaphase transition |
GO_0045582 | Biological process | positive regulation of T cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0045663 | Biological process | positive regulation of myoblast differentiation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0070316 | Biological process | regulation of G0 to G1 transition |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_2000819 | Biological process | regulation of nucleotide-excision repair |
GO_0045596 | Biological process | negative regulation of cell differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006337 | Biological process | nucleosome disassembly |
GO_2000781 | Biological process | positive regulation of double-strand break repair |
GO_0007399 | Biological process | nervous system development |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0071398 | Biological process | cellular response to fatty acid |
GO_0140288 | Cellular component | GBAF complex |
GO_0071565 | Cellular component | nBAF complex |
GO_0071564 | Cellular component | npBAF complex |
GO_0000776 | Cellular component | kinetochore |
GO_0016514 | Cellular component | SWI/SNF complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0016586 | Cellular component | RSC-type complex |
GO_0035060 | Cellular component | brahma complex |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SMARCD1 |
Protein name | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (60 kDa BRG-1/Brm-associated factor subunit A) (BRG1-associated factor 60A) (BAF60A) (SWI/SNF complex 60 kDa subunit) SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 Alternative protein SMARCD1 |
Synonyms | BAF60A |
Description | FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner . Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Has a strong influence on vitamin D-mediated transcriptional activity from an enhancer vitamin D receptor element (VDRE). May be a link between mammalian SWI-SNF-like chromatin remodeling complexes and the vitamin D receptor (VDR) heterodimer . Mediates critical interactions between nuclear receptors and the BRG1/SMARCA4 chromatin-remodeling complex for transactivation . Interacts with AKIRIN2 (By similarity). . |
Accessions | L8EC99 ENST00000548573.5 H0YHV1 F8VUB0 ENST00000551966.5 F8VZ70 ENST00000394963.9 [Q96GM5-1] ENST00000381513.8 [Q96GM5-2] Q96GM5 ENST00000550477.5 F8VW95 ENST00000551497.1 ENST00000549274.1 F8VRQ4 |